SARS-CoV-2 (COVID-19) Nucleocapsid (N) Recombinant Protein-重组病毒蛋白-深圳欣博盛生物科技有限公司

首页产品中心重组病毒蛋白

SARS-CoV-2 (COVID-19) Nucleocapsid (N) Recombinant Protein

品牌：ProSci LLC

官网链接

说明书

折扣/货期

货号：10-080

规格：0.1 mg

目录价：￥8687.25

产品详情

* 以下信息仅供参考，详情请以原厂网站为准

产品名称:

SARS-CoV-2 (COVID-19) Nucleocapsid (N) Recombinant Protein

实验应用:

ELISA,WB

产品浓度:

0.5 mg/ml

表达系统:

HEK293 cells

保存温度:

We recommended to store this recombinant protein as received at 2-8˚C for up to one month. For longer-term storage, aseptically aliquot in working volumes without diluting and store at -80˚C. Avoid Repeated Freeze Thaw Cycles.

运输温度:

Dry Ice

产品形式:

Liquid

存储溶液:

This recombinant protein was 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.3 with no calcium, magnesium, or preservatives.

产地:

美国

生产商:

Prosci

功能与背景:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19), is an enveloped, single-stranded, positive-sense RNA virus that belongs to the Coronaviridae family 1. The SARS-CoV-2 genome, which shares 79.6% identity with SARS-CoV, encodes four essential structural proteins: the spike (S), envelope (E), membrane (M), and nucleocapsid protein (N) 2. The S protein is a transmembrane, homotrimeric, class I fusion glycoprotein that mediates viral attachment, fusion, and entry into host cells 3. Each ~180 kDa monomer contains two functional subunits, S1 (~700 a.a) and S2 (~600 a.a), that mediate viral attachment and membrane fusion, respectively. S1 contains two major domains, the N-terminal (NTD) and C-terminal domains (CTD). In both SARS-CoV and SARS-CoV-2, the CTD contains the receptor-binding domain (RBD), which binds to the angiotensin-converting enzyme 2 (ACE2) receptor on host cells 3-5. The NTD of SARS-CoV-2 does not bind to ACE2 6, and the function of NTD in SARS-CoV-2 infection is not well understood. In other CoVs, the NTD may promote attachment by binding to sugar moieties 7 and might play a role in the conformational change of S2 required for membrane fusion 8. While most neutralizing antibodies target the RBD domain and block receptor binding, potent neutralizing antibodies targeting NTD were isolated from convalescent COVID19 patients 9, identifying the NTD as an attractive candidate for vaccines and therapeutics. In addition, the NTD is a promising antigen for diagnostic tests, as there is only 53.5% homology between the NTD of SARS-CoV-2 and SARS-CoV 10.

纯度:

>95% by SDS Page

Accession #:

QHO62115

您可能感兴趣的产品

SARS-CoV-2 (COVID-19) Omicron Variant (B.1.1.529) Spike RBD Recombinant Protein

货号：21-801

SARS-CoV-2 (COVID-19) NSP8 Recombinant Protein

货号：97-097

SARS-CoV-2 (COVID-19) S RBD Recombinant Protein

货号：97-093

SARS-CoV-2 (COVID-19) S1 Recombinant Protein